Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Die Rehabilitation|January 21, 2021
[Role of Clinical, Sociomedical and Psychological Factors on Return to Work of Patients with Breast Cancer 6 Months after Rehabilitation]Oliver Rick, Monika Reuß-Borst, Timm Dauelsberg, et al.
Psycho-Oncology|May 18, 2018
NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancerOliver Rick, Monika Reuß-Borst, Timm Dauelsberg, et al.
International Journal of Colorectal Disease|February 18, 2009
Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery aloneOliver Nehls, Holger G Hass, Thomas Okech, et al.
British Journal of Cancer|January 10, 2008
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trialO Nehls, H Oettle, J T Hartmann, et al.
British Journal of Cancer|April 12, 2007
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAXO Nehls, T Okech, C-J Hsieh, et al.
British Journal of Cancer|July 14, 2011
Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trialS Stintzing, L Fischer von Weikersthal, U Vehling-Kaiser, et al.
Oncology Research and Treatment|June 1, 2025
Guidelines of Onkopedia: What Is New?Magdalena K Scheck, Salah-Eddin Al-Batran, Markus Borner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study groupNicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling-Kaiser, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2014
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trialJ C von Einem, V Heinemann, L Fischer von Weikersthal, et al.
Pageof 6